ExNCDIA: an explainable ensemble learning framework for predicting non-chemotherapy drug-induced agranulocytosis and interpreting structural associations
- 1Department of Pharmacy, Jieyang People's Hospital Jieyang 522000 China
Abstract
Non-chemotherapy drug-induced agranulocytosis (NCDIA) is a rare but life-threatening idiosyncratic toxicity whose mechanisms remain largely unresolved; for a subset of drugs, however, the risk has been linked to chemical structure through bioactivation, whereby reactive intermediates injure neutrophils and myeloid progenitors, and haptenate proteins to trigger immune-mediated destruction. Yet the structural features underlying this liability remain poorly defined, and interpretable models for flagging it during design are scarce. Here we report ExNCDIA, an explainable machine learning framework that predicts NCDIA liability directly from chemical structure. From a curated set of 906 drugs (371 NCDIA-positive and 535 NCDIA-negative), we benchmarked complementary open-source representations and imbalance-aware ensemble classifiers, and retained two balanced random forest models—one trained on RDKit molecular descriptors refined by genetic-algorithm feature selection (test ROC-AUC 0.850, MCC 0.591), the other on MACCS substructure keys (test ROC-AUC 0.847, MCC 0.518). Both showed balanced discrimination in training-set cross-validation and on the held-out test set. Crucially, Shapley additive explanations (SHAP) applied to these two non-overlapping representations converged on the same medicinal-chemistry signal: NCDIA risk rises with sulfur-containing pharmacophores, multiple aromatic rings, and nitrogen-bearing/arylamine cores—motifs prone to cytochrome P450- and myeloperoxidase-mediated oxidation to reactive metabolites—and falls with aliphatic, saturated-oxygenated scaffolds lacking such bioactivatable groups. Delivered as a freely accessible web tool, ExNCDIA couples quantitative prediction with interpretable structural associations, supporting early candidate prioritization and post-marketing risk assessment.
Related
- Predicting continuous load-settlement trajectories of bored piles: A GA-optimized weighted ensemble framework with explainable AI
- Predicting nanoparticle tumor delivery efficiency using explainable machine learning for cancer nanomedicine design
- Metapath-guided topology and domain knowledge fusion for predicting miRNA-drug-disease triplet resistance and sensitivity associations.
- When aggregation becomes the norm: interpreting experiments beyond their molecules
- Interpreting the Hall effect of highly doped conducting polymers
BibTeX
@article{huang2026exncdia,
title = {{ExNCDIA: an explainable ensemble learning framework for predicting non-chemotherapy drug-induced agranulocytosis and interpreting structural associations}},
author = {Xiaojie Huang and Shusong Jiang and Peineng Liu},
journal = {RSC Advances},
year = {2026},
month = nov,
doi = {10.1039/d6ra06159a},
url = {https://doi.org/10.1039/d6ra06159a},
note = {CC BY 3.0},
}
RIS
TY - JOUR
TI - ExNCDIA: an explainable ensemble learning framework for predicting non-chemotherapy drug-induced agranulocytosis and interpreting structural associations
AU - Xiaojie Huang
AU - Shusong Jiang
AU - Peineng Liu
PY - 2026
DA - 2026/11/05
JO - RSC Advances
DO - 10.1039/d6ra06159a
UR - https://doi.org/10.1039/d6ra06159a
AB - Non-chemotherapy drug-induced agranulocytosis (NCDIA) is a rare but life-threatening idiosyncratic toxicity whose mechanisms remain largely unresolved; for a subset of drugs, however, the risk has been linked to chemical structure through bioactivation, whereby reactive intermediates injure neutrophils and myeloid progenitors, and haptenate proteins to trigger immune-mediated destruction. Yet the structural features underlying this liability remain poorly defined, and interpretable models for flagging it during design are scarce. Here we report ExNCDIA, an explainable machine learning framework that predicts NCDIA liability directly from chemical structure. From a curated set of 906 drugs (371 NCDIA-positive and 535 NCDIA-negative), we benchmarked complementary open-source representations and imbalance-aware ensemble classifiers, and retained two balanced random forest models—one trained on RDKit molecular descriptors refined by genetic-algorithm feature selection (test ROC-AUC 0.850, MCC 0.591), the other on MACCS substructure keys (test ROC-AUC 0.847, MCC 0.518). Both showed balanced discrimination in training-set cross-validation and on the held-out test set. Crucially, Shapley additive explanations (SHAP) applied to these two non-overlapping representations converged on the same medicinal-chemistry signal: NCDIA risk rises with sulfur-containing pharmacophores, multiple aromatic rings, and nitrogen-bearing/arylamine cores—motifs prone to cytochrome P450- and myeloperoxidase-mediated oxidation to reactive metabolites—and falls with aliphatic, saturated-oxygenated scaffolds lacking such bioactivatable groups. Delivered as a freely accessible web tool, ExNCDIA couples quantitative prediction with interpretable structural associations, supporting early candidate prioritization and post-marketing risk assessment.
SN - 2046-2069
ER -